A Communication Tool to Assist Older Adults Facing Dialysis Choices

NCT04466865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 407

Last updated 2026-04-30

No results posted yet for this study

Summary

The purpose of this study is to test the effect of the "Best Case/Worse Case" (BC/WC) communication tool on receipt of palliative care and intensity of treatment at the end of life, quality of life, and quality of communication for older patients with end-stage renal disease (ESRD) receiving outpatient care at ten nephrology clinics. The intervention was developed and tested with acute care surgical patients at the University of Wisconsin (UW) and is now being testing to see if the intervention will work in a different setting.

The intervention will be tested with 320 older adults who have end-stage renal disease (ESRD) and are receiving care from a nephrologist enrolled in the study. Randomly assigned nephrologists within each site will receive the intervention (training to use the BC/WC tool) or to be in the waitlist control, meaning that they will not be offered BC/WC training until the end of the study, when all participants have been enrolled. Participants will be on follow up with surveys and chart review for up to two years after study enrollment. Caregivers will also be invited to participate and complete surveys.

Conditions

  • Palliative Care
  • Kidney Failure, Chronic
  • Decision Making
  • Decision Support Techniques
  • Renal Dialysis
  • Dialysis
  • Kidney Diseases
  • Nephrologists
  • Decision Aid
  • End of Life
  • End-Stage Renal Disease
  • Late-Stage Renal Disease
  • Communication
  • Life-Supporting Treatments

Interventions

OTHER

Best Case/Worst Case communication tool training

The communication tool promotes dialogue and patient deliberation, and supports shared decision making in the context of kidney disease. Building on a conceptual model of shared decision-making proposed and the practice of scenario planning the intervention is designed to lead to a discussion of participants preferences and consideration of outcomes. The nephrologist verbally describes the "best case," "worst case," and "most likely" outcomes for each treatment option-incorporating rich narrative from clinical experience and translation of probabilistic information-while drawing a diagram of those options. The nephrologist also writes details about each option on the diagram. The narrative and graphic help family and patients formulate and express preferences.

Sponsors & Collaborators

Principal Investigators

  • Margaret L Schwarze, MD, MPP, FACS · University of Wisconsin, Madison

  • Amar Bansal, MD · University of Pittsburgh

  • Katharine Cheung, MD, PhD · University of Vermont

  • Deidra Crews, MD · Johns Hopkins University

  • Katie Colborn, PhD · University of Colorado, Denver

  • Holly Koncicki, MD · Icahn School of Medicine at Mount Sinai

  • Jean Kutner, MD · University of Colorado, Denver

  • Daniel Lam, MD · University of Washington

  • Alvin Moss, MD · West Virginia University

  • Maya Rao, MD · Columbia University

  • Dawn Wolfgram, MD · Medical College of Wisconsin

  • Jeniann Yi, MD · University of Colorado, Denver

  • Tamara Isakova, MD, MMSc · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2025-11-10
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04466865 on ClinicalTrials.gov